EMQ: Effectiveness of Slow Back Stroke Massage and Murrotal Quran on Fatigue and Quality of Life of Patients Undergoing Haemodialysis
Sponsor
Universitas Muhammadiyah Yogyakarta (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05183815
Collaborator
(none)
30
1
4.1
Study Details
Study Description
Brief Summary
The study aimed to investigate the effectiveness of slow back stroke massage and murrotal Quran on fatigue and quality of life on patients undergoing hemodialysis.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Study Type:
Interventional
Anticipated Enrollment
:
30 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Effectiveness of Slow Back Stroke Massage and Murrotal Quran on Fatigue and
Anticipated Study Start Date
:
Jan 25, 2022
Anticipated Primary Completion Date
:
Mar 10, 2022
Anticipated Study Completion Date
:
May 30, 2022
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: massage
|
Other: slow stroke massage and murrotal quran
murrotal quran and slow stroke massage
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Level of Fatigue [4 weeks]
level of fatigue
- Level of quality of life [4 weeks]
level of quality of life
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- patients undergoing hemodialysis minimal 6 months
Exclusion Criteria:
- patients with hear impairment
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Universitas Muhammadiyah Yogyakarta
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Erna Rochmawati,
Associate Professor,
Universitas Muhammadiyah Yogyakarta
ClinicalTrials.gov Identifier:
NCT05183815
Other Study ID Numbers:
- UMYogyakarta
First Posted:
Jan 11, 2022
Last Update Posted:
Jan 11, 2022
Last Verified:
Dec 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: